FLUOXETINE HYDROCHLORIDE; OLANZAPINE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for fluoxetine hydrochloride; olanzapine and what is the scope of patent protection?
Fluoxetine hydrochloride; olanzapine
is the generic ingredient in two branded drugs marketed by Endo Operations, Epic Pharma Llc, Teva Pharms, and Lilly, and is included in five NDAs. Additional information is available in the individual branded drug profile pages.Four suppliers are listed for this compound.
Summary for FLUOXETINE HYDROCHLORIDE; OLANZAPINE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 4 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 4 |
Clinical Trials: | 16 |
DailyMed Link: | FLUOXETINE HYDROCHLORIDE; OLANZAPINE at DailyMed |
Recent Clinical Trials for FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Second Xiangya Hospital of Central South University | Phase 1/Phase 2 |
First Affiliated Hospital of Chongqing Medical University | Phase 1/Phase 2 |
First Affiliated Hospital of Zhejiang University | Phase 4 |
See all FLUOXETINE HYDROCHLORIDE; OLANZAPINE clinical trials
Pharmacology for FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Drug Class | Atypical Antipsychotic Serotonin Reuptake Inhibitor |
Mechanism of Action | Serotonin Uptake Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Paragraph IV (Patent) Challenges for FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
SYMBYAX | Capsules | fluoxetine hydrochloride; olanzapine | 6 mg/25 mg 12 mg/25 mg 6 mg/50 mg 12 mg/50 mg | 021520 | 1 | 2005-01-10 |
US Patents and Regulatory Information for FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Expired US Patents for FLUOXETINE HYDROCHLORIDE; OLANZAPINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lilly | SYMBYAX | fluoxetine hydrochloride; olanzapine | CAPSULE;ORAL | 021520-005 | Dec 24, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Lilly | SYMBYAX | fluoxetine hydrochloride; olanzapine | CAPSULE;ORAL | 021520-003 | Dec 24, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Lilly | SYMBYAX | fluoxetine hydrochloride; olanzapine | CAPSULE;ORAL | 021520-001 | Apr 9, 2007 | ⤷ Sign Up | ⤷ Sign Up |
Lilly | SYMBYAX | fluoxetine hydrochloride; olanzapine | CAPSULE;ORAL | 021520-002 | Dec 24, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Lilly | SYMBYAX | fluoxetine hydrochloride; olanzapine | CAPSULE;ORAL | 021520-002 | Dec 24, 2003 | ⤷ Sign Up | ⤷ Sign Up |
Lilly | SYMBYAX | fluoxetine hydrochloride; olanzapine | CAPSULE;ORAL | 021520-004 | Dec 24, 2003 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.